Peachaphol Chongvoranond, et al. “Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Prescription Rates Amongst Diabetologists for Type 2 Diabetes Patients With Albuminuric Diabetic Kidney Disease:: A Real-World Study at a Diabetes Center in Bangkok”. Journal of the ASEAN Federation of Endocrine Societies, vol. 40, no. 2, Nov. 2025, pp. 69-77, doi:10.15605/jafes.040.02.22.